Anifrolumab: Solution concentrate for I.V. infusion 300 mg in 2 mL; Saphnelo® Page last updated: 11 November 2022 Public Summary Document (PSD) July 2022 PBAC Meeting - (PDF 1.1MB) Public Summary Document (PSD) July 2022 PBAC Meeting - (Word 324KB)